IQVIA Holdings | IQV - Selling And Administration Expenses


IQVIA Holdings reported $574M in Selling and Administration Expenses for its fiscal quarter ending in June of 2026.





Selling And Administration Expenses Change Date
Accenture USD 2.96B 6.78M Mar/2026
Agilent USD 465M 11M Mar/2026
Bruker USD 238.9M 3.2M Jun/2026
Cardinal Health USD 1.62B 115M Jun/2026
Celltrion KRW 9.32B 3.39B Mar/2026
Charles River Laboratories USD 228.9M 69.47M Jun/2026
Cigna USD 3.47B 152M Jun/2026
Cognizant Technology Solutions USD 809M 18M Jun/2026
Cspc Pharmaceutical CNY 1.87B 95.62M Dec/2025
Danaher USD 2.07B 212M Jun/2026
Dentsply International USD 364M 13M Jun/2026
Deva Holding AS TRY 462.26M 48.18M Sep/2023
Dianthus Therapeutics USD 12.47M 5.89M Mar/2026
Divis Laboratories Ltd INR 3.4B 10M Jun/2025
Elevance Health USD 10.91B 309M Dec/2025
Humana USD 3.36B 614M Mar/2025
IBM USD 4.4B 1.42B Mar/2026
Illumina USD 273M 1000K Jun/2026
Infosys INR 7.53B 7.47B Jun/2026
Kangmei Pharma CNY 237.06M 37.35M Mar/2026
Knight Therapeutics CAD 35.45M 4.43M Dec/2025
Laboratorios Farma EUR 35.32M 2.75M Jun/2025
Laboratory Of America USD 577.2M 26.2M Jun/2026
Malin Corporation EUR 1.1M 400K Dec/2024
McKesson USD 2.26B 468M Jun/2026
Mettler Toledo International USD 263.33M 5.01M Jun/2026
Organigram Holdings CAD 22.01M 14.28M Mar/2026
Ovoca Bio EUR 617K 15K Dec/2025
Pharma Mar EUR 17.12M 1.82M Jun/2026
Qiagen NV USD 142.33M 60K Jun/2026
Quest Diagnostics USD 529M 25M Jun/2026
Revvity USD 278.58M 24.69M Jun/2026
Sartorius EUR 221.3M 0 Jun/2026
Sino Biopharmaceutical CNY 7.54B 2.23B Jun/2025
Thermo Fisher Scientific USD 1.91B 111M Jun/2026
Tilray USD 24.85M 1.7M Sep/2025
UnitedHealth USD 15.22B 1.44B Sep/2025
Veeva Systems USD 126.47M 1.39M Mar/2026
Veradigm USD 27.28M 5.24M Dec/2022
Waters USD 405M 11M Jun/2026
Zealand Pharma A/S 104M 12.19M Mar/2026
Zz Pientze Pharmaceu CNY 214.31M 42.4M Mar/2026